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technical issues of employing the domain
swapping approachwill certainly corrobo-
rate the merits of biological glycodiversifi-
cation, and enable the practical and scale-
up production of glycoconjugates free of
the limitations imposed by nature.
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Recent reports identify the oxygenase catalyzed production of 5-hydroxymethylcytosine as amodification to
mammalian DNA (Kriaucionis and Heintz, 2009; Tahiliani et al., 2009). This discovery has potential far-reach-
ing implications for epigenetic regulation and will stimulate efforts to identify new nucleic acid modifications.Modifications to genomic DNA include
methylation at the 5-position of cytosine
(C) baseswithin cytosine-guanine dinucle-
otide (CpG) sites. Production of 5-methyl-
cytosine (5mC) alters DNA structure
without interfering with base pairing, and
is recognized as an important epigenetic
modification. Active gene promoters
generally have a low abundance of 5mC,
because promoter methylation can cause
transcriptional repression. The formation
of 5mC is catalyzed by DNA methyltrans-
ferases (DNMTs) and regulates gene
expression patterns and initiates chro-
matin remodeling.
While plants employ pathways involving
5mC glycosylases and base excision
repair to reverse cytosine methylation,
attempts at identifying enzymes with
5mC reversal or modification activity in
metazoans have been extensive but
largely fruitless (reviewed in Ooi and Bes-
tor [2008]). However, in recent years, other
epigenetic modifications once believed to
be static, such as histone lysyl methyla-
tion, have been demonstrated to be
reversible.
The starting point that led Tahiliani
and colleagues (Tahiliani et al., 2009) to580 Chemistry & Biology 16, June 26, 2009 ªthe discovery of 5-hydroxymethylcytosine
(hmC) as a modification to mammalian
DNA was the identification of a previously
unknown member of the 2-oxoglutarate
(2OG)oxygenase family. 2OGoxygenases
couple the two-electron oxidation of sub-
strate to the oxidative decarboxylation of
2OG, and depend on Fe(II) as a cofactor.
While bacterial 2OG oxygenases catalyze
an extraordinarily wide range of oxidative
chemistry including epimerization, ring
closure, desaturation, and halogenation
reactions, the activities of identified meta-
zoan 2OG oxygenases have so far been
limited to hydroxylation and demethyla-
tion via hydroxylation (Loenarz and Scho-
field, 2008).
Human 2OG oxygenases are involved
in a diverse range of biological functions,
including histone demethylation, collagen
stabilization, DNA repair, hypoxia
sensing, and fatty acid metabolism (Loe-
narz and Schofield, 2008). Although the
catalytic domains of 2OG oxygenases
share a common, albeit sometimes dis-
torted, double-stranded b-helix (or jelly-
roll) fold (first observed in antibiotic
biosynthesis enzymes), they often have
little overall sequence conservation,2009 Elsevier Ltd All rights reserved
CHBIOL 1527_1528which impedes bioinformatic studies.
However, approaches based on structur-
ally informed sequence searches starting
from 2OG oxygenases with known func-
tions have led to the discovery of human
orthologs, including enzymes with impor-
tant biomedical functions.
In 1993, Borst and coworkers discov-
ered that the DNA of African trypano-
somes, protist parasites that causeAfrican
sleeping sickness, contained the unusual
base b-D-glucosylhydroxymethyl-uracil,
termed base J (Figure 1Ai). Their efforts
to understand the nature of this modifica-
tion and its role in expression led to the
proposal of two trypanosomatid J-binding
proteins JBP1 and JBP2 as thymidine
hydroxylases of the 2OG oxygenase
family (Yu et al., 2007). Starting fromstruc-
turally informed iterative sequence profile
searches using the JBP1 and JBP2 oxy-
genase domains, bioinformatic work from
Tahiliani et al. (2009) led to the prediction
of the three human enzymes TET1-3 as
Fe(II) and 2OG oxygenases that catalyze
5-methylcytosine hydroxylation (Fig-
ure 1Aii). TET1-3 appear to be part of the
wider TET/JBP fmaily, present minimally
in metazoans, fungi, and algae.
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tagged TET1 reduced 5mC levels in a
statistically significant manner, and this
effect was not observed with HA-TET1
mutated to impair the predicted Fe(II)
binding sites; however, the antibody
staining intensity of 5mC appeared unreli-
able. To investigate the effect of TET1
overexpression on 5mC levels more
accurately, the authors went on to ana-
lyze restriction enzyme-cleaved genomic
DNA, resolved using thin-layer chroma-
tography (TLC). An additional unidentified
species was observed and was associ-
ated with a decrease in 5mC abundance
in DNA from cells expressing wild-type,
but not mutant, TET1. The novel nucleo-
tide was unambiguously identified as
hmC by high-resolution mass spectrom-
etry, including MS-MS fragmentation
experiments comparing authentic hmC
prepared from non-glucosylated DNA of
T4 phage. Direct involvement of the
TET1 catalytic domain in hmC production
was ascertained by insect-cell purified re-
combinant protein using fully methylated
double-stranded DNA oligonucleotides.
Similar to other 2OG oxygenases, cata-
lytic activity was absolutely dependent
on both Fe(II) and 2OG. Interestingly,
thymine conversion to hmU was not
detectable in initial experiments, suggest-
ing TET1 may be specific for 5mC. It will
be important to analyze how this speci-
ficity is achieved.
The crucial question of whether hmC is
present in mammalian DNA at physiologi-
cally relevant levels was addressed by582 Chemistry & Biology 16, June 26, 2009 ªTahiliani et al. (2009) in different cell types.
While no significant levels of hmC were
found in some cell types, hmC was clearly
present in human embryonic stem (ES)
cells. Important evidence for the physio-
logical relevance of hmC comes from
a simultaneously published report. The
work of Kriaucionis and Heintz (2009)
provides important insights into the poten-
tial significance of hmC. Their work is
a nice example of how recognition of the
unexpected can lead to an important
discovery. When investigating levels of 5-
methylcytosine in the nuclei of cerebellar
cells (Purkinje and granule cells, the latter
making up > 50% of all neurons in the
central nervous system), they detected
the presence of an unexpected nucleo-
tide. Careful chromatographic and mass-
spectrometric analyses identified the
nucleotide as hmC. Importantly, both
studies find, at least in some cell types,
hmC as a significant fraction of the total
mC content. In DNA from Purkinje cells,
hmC is present at40%of the abundance
of mC (Kriaucionis and Heintz, 2009) and
as 4% to 6% of all observable cytosine
species within CpG sites in ES cells (Tahi-
liani et al., 2009). Tahiliani et al. (2009) esti-
mate the frequency of hmC at 1 in every
3000 nucleotides, a significant fraction,
especially if it is a regulatory modification.
Thepresence of hmCasa stable base in
genomic DNA also raises questions as to
the validity of the widely used ’’bisulfite’’
method for the determination of 5mC
levels during DNA sequencing. Bisulfite
treatment enables 5mC to be distin-2009 Elsevier Ltd All rights reserved
CHBIOL 1527_1528guished from cytosine, because 5mC
produces an intermediate that is more
stable with respect to deamination,
whereas cytosine is rapidly converted to
uracil (Figure 1B). However, there is
evidence that the analogous intermediate
formed by reaction of hmC with bisulfite
is more stable than that formed from
5mC (Hayatsu and Shiragami, 1979).
Further, the product of the reaction with
hmC, cytosine 5-methylenesulfonate (or
related modifications), may directly inter-
fere with sequencing. Thus, the results of
the numerous studies based on bisulfite
sequencing may need to be reassessed.
The development of efficient sequencing
methodology that simultaneously distin-
guishes hmC, 5mC, and C is now an im-
portant challenge. Tahiliani et al. (2009)
also point out that the presence of hmC
affects the selectivity of methylation-
specific restriction endonucleases, and
they argue that the results obtained using
these reagents need to be reassessed.
An analogous limitation applies to the
use of proteases in proteomic analyses;
for example, trypsin-mediated cleavage
at lysyl residues is hinderedbyacetylation.
In recent years, advances in analytical
techniques, coupled with an enhanced
realization of the biomedical importance
of post-translational modifications, have
led to the identification of many new
modifications to proteins. Recent work
has suggested that 2OG oxygenases
catalyze many post-translational modifi-
cations. Following the identification of
their role in metazoan oxygen sensing,Figure 1. Involvement of 2OG Oxygenases in Nucleic Acid and Nucleoside Modifications
(A) 2OG oxygenase catalyzed hydroxylations (enzyme acronyms in red) are coupled to the conversion of 2OG and O2 to CO2 and succinate. Both N-and C-alky-
lated DNA/RNA are hydroxylated by 2OG oxygenases: (i) thymidine 5-hydroxylation is catalyzed by JBP1/2 in kinetoplastids during base J biosynthesis (Yu et al.,
2007); (ii) 5-hydroxymethylcytosine (hmC) is formed as a stable base by human TET1 and might be subject to subsequent modifications; (iii) reversal of N-alkyl-
ation damage to DNA/RNA by hydroxylation proceeds via fragmentation of the unstable intermediate. FTO (3mT, 1mA, 3mC and 3mU RNA) and ALKBH3 (1mA
and 3mC) prefer ssDNA, while ALKBH2 (1mA and 3mC) prefers dsDNA; AlkB (1mA, 3mC, 1mG, 3mT) prefers ssDNA over dsDNA and RNA; it can also remove
ethyl- and etheno-DNA lesions (Gerken et al., 2007; Sedgwick et al., 2007).
(B) Bisulfite sequencing (boxed: modification present at the end of a typical bisulfite reaction) converts cytosine to uracil (i) while retaining 5mC (ii), thus enabling
identification of 5mC sites by sequencing. (iii) Under these conditions, the newly identified base hmCwould react to cytosine 5-methylenesulfonate, which is likely
to interfere with subsequent analyses. Investigation of the stability of the different bases towards deamination resulted in approximate half-lives of 6min, 8 hr, and
28 hr for C, 5mC, and hmC, respectively (Hayatsu and Shiragami, 1979).
(C) Active sites of 2OG oxygenases involved in DNA and histone hydroxylation/demethylation: (i) AlkB, the DNA demethylase from E. coli involved in DNA repair
(Protein Data Bank (PDB) code 3BIE); (ii) human ALKBH2, involved in reversal of DNA N-alkylation (PDB code 3BUC); (iii) human jumonji domain-containing
protein 2A (JMJD2A), involved in demethylation of methyl-lysyl histone residues (PDB code 2OQ6). Color code: grey-brown, double-stranded b-helix fold; yellow,
substrate; orange, Fe(II)-binding residues; white, 2OG or N–oxalylglycine (NOG). Note in these structures Ni(II) and Mn(II) substitute for Fe(II).
(D) A large subfamily of 2OG oxygenases is involved in the reversal of histone lysyl-methylation using chemistry analogous to that of DNA demethylases.
(E) Other base/nucleoside modifications known to be catalyzed by 2OG oxygenases in eukaryotes (Simmons et al., 2008): (i) thymine 7-hydroxylase (T7H) from
Neurospora crassa catalyzes sequential thymine oxidation as part of the pyrimidine salvage pathway; (ii) pyrimidine deoxyribonucleoside 20-hydroxylation byP2H
has been shown inN. crassa, Aspergillus nidulans, andRhodotorula glutinis; (iii) 10-hydroxlation of both deoxyuridine and uridine by U1H inR. glutinis; (iv) xanthine
hydroxylation by XanA in A. nidulans. The requirement by oxygenases for 2OG, Fe(II), and the coproducts succinate and CO2, is omitted for clarity. Color codes:
red, hydroxylation reactions and incorporated oxygen; blue, methylation reactions andmethyl residue acted upon. Abbreviations: dsDNA, double-stranded DNA;
K9me3, histone trimethyllysyl-9; 1mA, 1-methyladenine, 1mG, 1-methylguanine; 3mC, 3-methylcytosine; 3mT, 3-methylthymine; 3mU, 3-methyluracil; 5mU,
5-methyluracil; 5mC, 5-methylcytosine; hmC, 5-hydroxymethylcytosine; hmU, 5-hydroxymethyluracil; SAM, S-adenosylmethionine; ssDNA, single-stranded
DNA.
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to catalyze the post-translational hydrox-
ylation of proteins containing the ubiqui-
tous ankyrin repeat domain, providing
evidence that intracellular protein
hydroxylation is common (Cockman
et al., 2006). 2OG oxygenases (the Jmj
subfamily) have also emerged as the
largest family of histone methyl-lysyl de-
methylases (Figures 1C and 1D). Pres-
ently, it is unclear whether the plethora of
post-translational modifications will be re-
flected in modifications to nucleic acids.
However, the recent reports on hmC will
both further stimulate systematic
searches for such modifications and alert
the scientific community to their potential
importance.
The overall extent to which DNA/RNA-
modifying 2OG oxygenases, such as
TET1, play a role in nucleic acid modifica-
tions is unclear (as is whether or not they
are involved in oxygen sensing). Members
of the human AlkB homolog family
(ALKBH1-8) are believed to enable repair
of DNA/RNA damage by base N-methyla-
tion via a hydroxylation fragmentation
mechanism that is analogous to that of
the histone demethylases (Figures 1Aiii,
1C, and 1D) (Sedgwick et al., 2007). The
fat mass and obesity associated protein
(FTO) is related to the ALKBHs, and cata-
lyzes theN-demethylation of 3-methylthy-
mine oligonucleotides (Figure 1A) (Gerken
et al., 2007). Mutations associated
with FTO are linked to an increased riskof obesity revealing that at least one
nucleic acid modifying 2OG oxygenase
is important from a pathophysiological
perspective.
Identifying the roles of the hmC modifi-
cation at molecular, cellular, and phys-
iological levels is now an important
objective. One possibility is that 5-
hydroxylation enables further modifica-
tions, as occurs in base J production
(Figure 1Ai); intriguingly, the hmChydroxyl
group is known to be exposed and acces-
sible to external reagents, even within
double-stranded DNA (Hayatsu and
Shiragami, 1979). A recent study reports
the direct reversible conversion of hmC
within double-stranded DNA to unmodi-
fied cytosine and free formaldehyde, via
covalent catalysis by a bacterial DNMT
lacking cofactors (Liutkeviciute et al.,
2009). This work thus suggests a possible
(reversible) mechanism for removal of
the hmC hydroxylation mark. Another
possibility is that further oxidation at
the cytosine 5-position occurs, either to
enable chemical demethylation or to
reverse the function of cytosine 5-meth-
ylation. Precedents for this chemistry
are modifications to bases/nucleosides
catalyzed by 2OG oxygenases in micro-
organisms (Figure 1E). It may be that
some of the other base/nucleoside mod-
ifications catalyzed by 2OG oxygenases
in micro-organisms, including deoxyri-
bose 20-hydroxylation, also occur in
animals.Chemistry & Biology 16, June 26, 200
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